CODX vs WTW · rev $3.9M vs P/E 15, rev $9.93B
Co-Diagnostics, Inc. Common Stock (CODX) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
CODX currently screens at market cap $31.4M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the CODX and WTW stock pages for the full models.
Not investment advice.